Raymond James Financial Inc. Buys Shares of 310,793 Select Medical Holdings Co. (NYSE:SEM)

Raymond James Financial Inc. purchased a new stake in shares of Select Medical Holdings Co. (NYSE:SEM) during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 310,793 shares of the health services provider’s stock, valued at approximately $5,858,000.

Other hedge funds have also recently modified their holdings of the company. Kingsview Wealth Management LLC acquired a new position in Select Medical in the 3rd quarter valued at about $1,927,000. JPMorgan Chase & Co. increased its holdings in shares of Select Medical by 9.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 416,299 shares of the health services provider’s stock worth $14,516,000 after buying an additional 36,905 shares during the last quarter. Dynamic Technology Lab Private Ltd acquired a new position in Select Medical in the third quarter valued at approximately $1,592,000. Argent Capital Management LLC lifted its holdings in Select Medical by 79.8% in the fourth quarter. Argent Capital Management LLC now owns 55,144 shares of the health services provider’s stock valued at $1,039,000 after acquiring an additional 24,471 shares during the last quarter. Finally, Geode Capital Management LLC increased its stake in Select Medical by 2.0% during the third quarter. Geode Capital Management LLC now owns 2,442,321 shares of the health services provider’s stock worth $85,180,000 after acquiring an additional 46,880 shares during the last quarter. Hedge funds and other institutional investors own 89.48% of the company’s stock.

Select Medical Stock Performance

NYSE SEM opened at $16.88 on Tuesday. The company has a debt-to-equity ratio of 1.37, a current ratio of 1.13 and a quick ratio of 1.13. The company has a market cap of $2.18 billion, a P/E ratio of 10.23, a P/E/G ratio of 0.64 and a beta of 1.56. The stock has a 50-day moving average of $18.55 and a two-hundred day moving average of $25.43. Select Medical Holdings Co. has a 1-year low of $16.20 and a 1-year high of $40.98.

Select Medical (NYSE:SEM) last announced its quarterly earnings data on Thursday, February 20th. The health services provider reported $0.18 earnings per share for the quarter, missing analysts’ consensus estimates of $0.29 by ($0.11). Select Medical had a net margin of 3.23% and a return on equity of 14.04%. The business had revenue of $1.31 billion during the quarter, compared to analyst estimates of $1.50 billion. As a group, analysts anticipate that Select Medical Holdings Co. will post 1.17 EPS for the current year.

Select Medical Cuts Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, March 13th. Investors of record on Monday, March 3rd were issued a $0.0625 dividend. The ex-dividend date was Monday, March 3rd. This represents a $0.25 dividend on an annualized basis and a yield of 1.48%. Select Medical’s dividend payout ratio (DPR) is presently 15.15%.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on SEM shares. UBS Group decreased their price target on Select Medical from $40.00 to $21.00 and set a “neutral” rating on the stock in a research note on Friday, January 3rd. Benchmark raised shares of Select Medical from a “hold” rating to a “buy” rating and set a $23.00 target price for the company in a research note on Monday, February 24th. Royal Bank of Canada reduced their price target on shares of Select Medical from $47.00 to $23.00 and set an “outperform” rating on the stock in a research note on Monday, February 24th. Finally, StockNews.com raised shares of Select Medical from a “hold” rating to a “buy” rating in a research report on Friday, February 21st. One analyst has rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $27.25.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.